# Evolent Health (EVH) — Earnings

EVH · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/evh/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.02 |
| EPS estimate | −$0.01 |
| EPS surprise | +292.31% |
| Revenue surprise | +9.17% |
| Revenue | $652.5M |
| Revenue estimate | $597.7M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1628908/000162890826000086/evh-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/a82f48be-7f9e-7718-4340-c6fa90992a3f.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | −$0.01 | $0.02 | 292.31% | $597.7M | $652.5M |
| Q1 2026 | May 7, 2026 | −$0.05 | −$0.02 | 58.85% | $534.0M | $496.2M |
| Q4 2025 | Feb 24, 2026 | $0.05 | $0.08 | 56.56% | $468.7M | $468.7M |
| Q3 2025 | Nov 6, 2025 | $0.10 | $0.05 | -48.93% | $468.2M | $479.5M |
| Q2 2025 | Aug 7, 2025 | $0.07 | −$0.10 | -234.77% | $459.0M | $444.3M |
| Q1 2025 | May 8, 2025 | $0.09 | $0.06 | -36.10% | $460.7M | $483.6M |
| Q4 2024 | Feb 20, 2025 | $0.03 | −$0.02 | -166.45% | $651.3M | $646.5M |
| Q3 2024 | Nov 7, 2024 | $0.31 | $0.04 | -87.08% | $627.2M | $621.4M |
| Q2 2024 | Aug 8, 2024 | $0.24 | $0.30 | 25.42% | $636.8M | $647.1M |
| Q1 2024 | May 9, 2024 | $0.24 | $0.34 | 41.02% | $600.8M | $639.7M |
| Q4 2023 | Feb 22, 2024 | $0.17 | $0.23 | 38.14% | $542.4M | $556.1M |
| Q3 2023 | Nov 2, 2023 | $0.10 | $0.30 | 191.26% | $509.4M | $511.0M |
| Q2 2023 | Aug 2, 2023 | $0.15 | $0.14 | -9.62% | $460.7M | $469.1M |
| Q1 2023 | May 3, 2023 | $0.17 | $0.21 | 22.95% | $434.3M | $427.7M |
| Q4 2022 | Feb 22, 2023 | $0.10 | $0.10 | 2.35% | $372.9M | $382.4M |
| Q3 2022 | Nov 2, 2022 | $0.12 | $0.59 | 397.47% | $356.8M | $352.6M |
| Q2 2022 | Aug 2, 2022 | $0.05 | $0.10 | 105.76% | $298.8M | $319.9M |
| Q1 2022 | May 4, 2022 | −$0.00 | $0.12 | 6100.00% | $286.8M | $297.1M |
| Q4 2021 | Feb 23, 2022 | $0.01 | $0.08 | 863.86% | $233.9M | $248.4M |
| Q3 2021 | Nov 3, 2021 | −$0.03 | −$0.03 | 12.54% | $226.0M | $222.5M |

## Frequently Asked Questions

### When did Evolent Health (EVH) last report earnings?

Evolent Health last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did EVH beat earnings estimates?

Yes. Evolent Health reported EPS of $0.02 for Q2 2026 against a −$0.01 estimate — a 292.31% beat.

### How much revenue did EVH report last quarter?

Evolent Health reported $652.5M in revenue for Q2 2026, against a consensus estimate of $597.7M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).